Cancer Control Research: OCS Analysis for FY 2004
Overview of the Fiscal Year (FY) 2004 National Institutes of Health (NIH)/Office of Cancer Survivorship (OCS) Research Grant Portfolio
- For this portfolio analysis, survivorship research was defined as that which focused on the health and life of a person with a history of cancer beyond the acute diagnosis and treatment phase.
- Studies that examined newly diagnosed survivors or those in active treatment were included in the portfolio analysis if follow-up extended at least two months or longer post-treatment.
- Studies addressing recurrence or end-of-life research were not included in this particular analysis.
Map 1 shows the distribution of the FY 2004 survivorship research grants by Principal Investigator's (PI) state. California-based PIs hold the largest number of grants (N =22), followed by those in Pennsylvania (N = 18). Over half of the grants (N = 118) are located at an NCI-designated comprehensive or clinical cancer center. It should be noted that this map does not reflect the fact that many PIs lead collaborative studies which may include co-investigators at additional performance sites within and outside of the PI's home state.
Map 2 shows the distribution of the FY 2004 pediatric survivorship research grants by home state of the PI. Pediatric survivorship includes cancer survivors who were 21 years or younger at the time of diagnosis. Although not reflected on this map, 60% (N = 25) of the pediatric research grants included investigators at additional performance sites within and outside of the PI's home state.
Chart 1 shows the distribution of the FY 2004 survivorship research grants by primary NIH funding institute. The National Cancer Institute holds 85% (N = 181) of these grants.
Chart 2 shows the distribution of the FY 2004 survivorship research grants by grant mechanism. R01 grants make up almost half (49%) of the portfolio.
Chart 3 shows the distribution of FY 2004 survivorship research grants by cancer site and study design. Female breast cancer is the most studied cancer site (N = 90) followed by hematologic cancer (N = 33) and prostate cancer (N = 21).
Chart 4 shows the distribution of FY 2004 survivorship research grants by identified late/long-term effect and study design. Psychological distress (N = 104) is the most prevalent area of study followed by health behavior outcomes (N = 56). Over half of the psychological distress grants are descriptive studies, while 60% of those focused on health behavior represent intervention studies.
Chart 5 shows the distribution of FY 2004 survivorship research grants by primary study population (e.g. family caregivers, long-term survivors, pediatric survivors). Funding in 2004 for the renewed Long-Term Cancer Survivors' Request for Application resulted in 17 grants being added to research among survivors 5 or more years post-diagnosis. As reflected in the chart, studies among survivors of pediatric cancer continue to provide important data on the ongoing burden of cancer.
Chart 6 shows the distribution of FY 2004 survivorship PIs by type of advanced degree held. Of those PIs who specified areas of expertise on their grant application (N =111), Behavioral Science (N = 37), Clinical Medical Science (N= 31), Epidemiology (N = 24) and Health Services Research (N = 15) were the most common areas identified. PIs may choose to identify more than one area of expertise. It should be noted that 25 PIs have more than one survivorship research grant supported by NIH; PI degree and expertise were only counted once.